Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sirolimus Drug-coated Balloon Versus Stent Graft for Thrombosed Arteriovenous Graft (SUSTAIN)

NCT05938530 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT05938530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05938530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sirolimus Drug-coated Balloon Versus Stent Graft for Thrombosed Arteriovenous Graft (SUSTAIN)
Lead sponsor
Singapore General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2023
Completion date
August 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous shunt thrombosis, blood vessel prosthesis